Pharma Must Unite On MFN Launch Prices To Boost Rates Abroad, CMS’ Brooks Says

 
• By Cathy Kelly
  
Can manufacturers march in lockstep on launch prices? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access